Department of Anal-Rectal Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China.
Adv Clin Exp Med. 2023 May;32(5):563-573. doi: 10.17219/acem/156647.
Dextran sulfate sodium (DSS)-induced murine colitis is the most commonly used model for the analysis of the pathogenesis of inflammatory bowel disease (IBD) and for the assessment of the efficacy of putative therapeutics. It has been suggested that mice should be given 2.5-10% DSS for 3-7 days to establish the model.
To compare the IBD model in C57BL/6J mice given free access to water containing DSS at concentrations of 2.0%, 2.5% or 3.0% for 5, 7 or 10 days.
Female mice (9 weeks old) were given access to drinking water containing DSS (2.0%, 2.5% or 3.0%) for 5-10 days. Body weight and colon length were then measured. Signs of edema, epithelial layer disruption, inflammatory cell infiltration, and cytokine induction, and severe colitis-related clinical signs were observed and analyzed.
Weight of the mice decreased and disease activity index (DAI) score immediately increased in all 3 groups. The colon of mice in the 3.0% DSS group was shortened after 5 days, and the colon of mice in the 2.0% and 2.5% DSS groups was shortened after 7 days. A significantly increased intestinal injury score was observed on day 5 in the 3.0% DSS group, on day 7 in the 2.5% DSS group and on day 10 in the 2.0% DSS group. Cytokines were found to be elevated in all 3 groups after 5 days of DSS exposure, with higher DSS concentrations and longer administration times found to be associated with more serious inflammation of the intestinal tract. After 10 days of DSS administration, all mice in the 3.0% DSS group died.
It took 10 days for the 2.0% DSS group, 5 days for the 3.0% DSS group and 7 days for the 2.5% DSS group to develop obvious observable changes related to the induction of the IBD model. The individual differences within groups (within 10 days) could be reduced by prolonging the administration time. Excessive DSS concentration and longer DSS administration time (exceeding 7 days) may increase mortality of the mice.
葡聚糖硫酸钠(DSS)诱导的小鼠结肠炎是分析炎症性肠病(IBD)发病机制和评估潜在治疗方法疗效的最常用模型。有人建议,应该用 2.5-10%的 DSS 给小鼠喂食 3-7 天来建立模型。
比较 C57BL/6J 小鼠在自由饮用浓度为 2.0%、2.5%或 3.0%的 DSS 水 5、7 或 10 天的 IBD 模型。
给 9 周龄雌性小鼠饮用含 DSS(2.0%、2.5%或 3.0%)的饮用水 5-10 天。然后测量体重和结肠长度。观察和分析水肿、上皮层破坏、炎症细胞浸润和细胞因子诱导以及严重结肠炎相关临床症状。
三组小鼠体重均下降,疾病活动指数(DAI)评分立即升高。3.0%DSS 组小鼠的结肠在第 5 天缩短,2.0%和 2.5%DSS 组的结肠在第 7 天缩短。第 5 天 3.0%DSS 组的肠道损伤评分显著升高,第 7 天 2.5%DSS 组和第 10 天 2.0%DSS 组升高。所有三组小鼠在 DSS 暴露 5 天后细胞因子升高,DSS 浓度越高,给药时间越长,肠道炎症越严重。10 天后,3.0%DSS 组所有小鼠均死亡。
2.0%DSS 组 10 天、3.0%DSS 组 5 天、2.5%DSS 组 7 天出现与 IBD 模型诱导相关的明显可观察变化。通过延长给药时间,可以减少组内(10 天内)的个体差异。DSS 浓度过高和 DSS 给药时间过长(超过 7 天)可能会增加小鼠的死亡率。